查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869789

控制释放药物递送市场规模、份额和趋势分析报告：按技术、释放机制、应用、地区和细分市场预测（2025-2033 年）

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application (Metered Dose Inhalers, Injectable), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

控制释放药物递送市场摘要

2024年全球控制释放药物递送市场规模估计为598亿美元，预计2033年将达到1,486亿美元。

预计从 2025 年到 2033 年，该市场将以 10.7% 的复合年增长率成长。医师处方模式的改变，以及对缓释性药物递送系统（而非传统系统）的偏好日益增强（因为缓释药物递送系统具有更高的治疗效果、更好的患者依从性和更低的治疗成本等优势），预计将在预测期内促进市场成长。

此外，在竞争激烈且分散的市场中运营的製药公司正在积极响应不断变化的市场需求，并不断投资于控制释放药物输送的开发，这推动了巨大的需求。

製药公司持续增加研发投入，致力于开发治疗癌症、糖尿病、高血压等慢性病和非传染性疾病的有效治疗方法，预计将推动预测期内市场成长。例如，艾伯维、Astra Zeneca和默克等缓释性製药公司已推出缓释药物系统，以提高治疗慢性病、癌症和神经系统疾病的疗效。

全球老年人和儿童人口的不断增长是推动市场成长的主要因素之一。这主要是由于这些年龄层普遍存在用药依从性低的问题。老年人的生理、心理和生物机能下降，这会影响药物摄取。他们也更难耐受高剂量药物和严重的药物副作用。因此，随着患者数量的指数级增长，对控制释放药物的需求也将随之增长。

製药公司持续增加研发投入，致力于开发治疗癌症、糖尿病、高血压等慢性病和非传染性疾病的有效治疗方法，预计将推动预测期内市场成长。例如，艾伯维、Astra Zeneca和默克等缓释性製药公司已推出缓释药物系统，以提高治疗慢性病、癌症和神经系统疾病的疗效。

全球老年人口和儿童人口的成长是推动市场成长的主要因素之一。这主要是由于这些年龄层普遍存在用药依从性低的问题。老年人的生理、心理和生物机能逐渐衰退，影响了药物的摄取。此外，老年人的身体也无法耐受高剂量药物及其强烈的副作用。因此，随着患者数量的指数级增长，对缓释性给药系统的需求也将随之增长。

缓释性给药系统可显着降低剂量和给药频率，防止血浆药物浓度异常波动，提高疗效，增强患者依从性，并确保给药效果的一致性。与传统给药系统相比，缓释性给药系统能够以预定的速率将药物输送到靶点，并具有可预测的药物释放动力学，从而延长治疗效果。缓释性给药系统带来的许多益处预计将在预测期内显着推动其应用范围的扩大。

目录

第一章调查方法和范围

第二章执行摘要

第三章控制释放药物递送市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 渗透率和成长前景分析
  • 产业价值链分析
    • 报销框架
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 控制释放药物递送市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
    • 重大交易和策略联盟分析
    • 打入市场策略

第四章 全球控制释放药物递送市场：技术预测与趋势分析

  • 细分仪表板
  • 控制释放药物递送市场波动分析
  • 控制释放药物递送市场展望
  • 市场规模、预测与趋势分析，2021-2033年
  • 伍斯特技术
  • 凝聚
  • 微胶囊化
  • 植入
  • 经皮
  • 其他（电子机械技术、脂质体）

第五章 全球控制释放药物递送市场：释放机制评估与趋势分析

  • 细分仪表板
  • 控制释放药物递送市场波动分析
  • 控制释放药物递送市场展望
  • 市场规模、预测与趋势分析，2021-2033年
  • 基于聚合物基质的系统
  • 微储库分区控制药物递送系统
  • 回馈控制药物传输系统
  • 活化式控释药物输送系统
  • 化学活化

第六章 全球控制释放药物递送市场：应用预测与趋势分析

  • 细分仪表板
  • 控制释放药物递送市场波动分析
  • 控制释放药物递送市场展望
  • 市场规模、预测与趋势分析，2021-2033年
  • 定量喷雾吸入器
  • 注射
  • 经皮吸收贴片和眼用贴剂
  • 点滴帮浦
  • 口服控释药物传递系统
  • 药物释放型支架

第七章 全球控制释放药物递送市场：区域估算与趋势分析

  • 区域仪錶板
  • 区域控制释放药物递送市场波动分析
  • 控制释放药物递送市场：按产品和最终用途分類的区域估算和趋势分析
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Johnson &Johnson
    • Pfizer Inc.
    • Merck &Co., Inc.
    • AbbVie Inc.
    • Novartis AG
    • Bayer AG
    • AstraZeneca plc
    • Corium International, Inc
    • Alkermes plc
    • Amneal Pharmaceuticals
Product Code: GVR-2-68038-347-8

Controlled Release Drug Delivery Market Summary

The global controlled release drug delivery market size was estimated at USD 59.8 billion in 2024 and is projected to reach USD 148.6 billion by 2033, growing at a CAGR of 10.7% from 2025 to 2033. Changing prescription patterns of physicians preferring controlled-release drug delivery over conventional systems, owing to the benefits such as high therapeutic efficacy, better patient compliance, and reduced treatment cost, is expected to contribute to the market's growth over the forecast period.

Moreover, being a part of a highly competitive and fragmented market, pharmaceutical companies are proactive with the changing market requirements and continuously invest in developing controlled-release drug delivery systems, thereby significantly driving the demand.

Constantly rising R&D expenditure by pharmaceutical development companies focused on developing efficient therapy for chronic and non-communicable complications such as cancer, diabetes, and hypertension is expected to boost the market growth over the forecast period. For instance, Major pharmaceutical companies such as AbbVie, AstraZeneca, and Merck are implementing controlled drug release systems to enhance the treatment of chronic diseases, cancer, and neurological disorders.

The rising global geriatric and pediatric population is one of the major factors contributing to market growth, largely due to non-adherence to the medicine regimen, which is very common among these age groups. Geriatric populations suffer from compromised physical, mental, and biological functions that affect their medication intake. Also, their bodies cannot tolerate high doses and harsh drug side effects. Thus, the demand for controlled-release drug delivery systems is expected to grow with a steeply rising patient population.

Constantly rising R&D expenditure by pharmaceutical development companies focused on developing efficient therapies for chronic and non-communicable complications such as cancer, diabetes, and hypertension is expected to boost the market growth over the forecast period. For instance, Major pharmaceutical companies such as AbbVie, AstraZeneca, and Merck are implementing controlled drug release systems to enhance the treatment of chronic diseases, cancer, and neurological disorders.

The rising geriatric and pediatric population globally is one of the major factors contributing to market growth, largely due to non-adherence to the medicine regimen, which is very common among these age groups. Geriatric populations suffer from compromised physical, mental, and biological functions that affect their medication intake. Also, their bodies cannot tolerate high doses and the harsh side effects of drugs. Thus, the demand for controlled-release drug delivery systems is expected to grow with a steeply rising patient population.

Controlled release drug delivery significantly reduces dose and dosage frequency, prevents abnormal fluctuations of plasma drug levels, improves efficacy, enhances patient compliance, and achieves a uniform drug effect of the administered drug. Compared to traditional delivery systems, the controlled-release drug delivery systems achieve a prolonged therapeutic effect, delivering the drug at the target site at a pre-determined rate and with predictable drug release kinetics. Thus, with several added benefits offered by the controlled release delivery system, their adoption is expected to increase notably over the forecast period.

Global Controlled Release Drug Delivery Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global controlled release drug delivery market report based on technology, release mechanism, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others (Microelectromechanical Technology, Liposomes)
  • Release Mechanism Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated
  • Activation-modulated Drug Delivery Systems Outlook (Revenue, USD Million, 2021 - 2033)
  • Osmotic Pressure Activated
  • Hydrodynamic Pressure Activated
  • Vapor Pressure Activated
  • Mechanically Activated
  • Magnetically Activated
  • Chemically Activated (Revenue, USD Million, 2021 - 2033)
  • pH Activated
  • Hydrolysis Activated
  • Enzyme Activated
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-Drug Delivery Systems
  • Drug-Eluting Stents
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherland
    • Switzerland
    • Russia
    • Belgium
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Thailand
    • South Korea
    • Indonesia
    • Philippines
    • Vietnam
    • Singapore
    • Malaysia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Israel

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Release mechanism
    • 1.1.3. Application
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Release mechanism outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Controlled Release Drug Delivery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric populations
      • 3.4.1.2. Increased compliance due to the nature of dosage forms
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited amount of controlled-release dosage forms is acceptable for usage in pediatric conditions
      • 3.4.2.2. Need for high dose of active pharmaceutical ingredient
  • 3.5. Controlled Release Drug Delivery Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
      • 3.5.2.4. Social landscape
      • 3.5.2.5. Environmental landscape
      • 3.5.2.6. Legal landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Global Controlled-Release Drug Delivery Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Controlled Release Drug Delivery Market: Technology Movement Analysis
  • 4.3. Controlled Release Drug Delivery Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Wurster Technique
    • 4.5.1. Wurster Technique Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Coacervation
    • 4.6.1. Coacervation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Micro Encapsulation
    • 4.7.1. Micro Encapsulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Implants
    • 4.8.1. Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Transdermal
    • 4.9.1. Transdermal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Others (Microelectromechanical Technology, Liposomes)
    • 4.10.1. Others (Microelectromechanical Technology, Liposomes) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Global Controlled-Release Drug Delivery Market: Release Mechanism Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Controlled Release Drug Delivery Market: Release Mechanism Movement Analysis
  • 5.3. Controlled Release Drug Delivery Market by Release Mechanism Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Polymer Matrix-Based Systems
    • 5.5.1. Polymer Matrix-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Micro Reservoir Partition Controlled Drug Delivery Systems
    • 5.6.1. Micro Reservoir Partition Controlled Drug Delivery Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Feedback Regulated Drug Delivery Systems
    • 5.7.1. Feedback Regulated Drug Delivery Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Activation-modulated Drug Delivery Systems
    • 5.8.1. Activation-modulated Drug Delivery Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.8.1.1. Osmotic Pressure Activated
        • 5.8.1.1.1. Osmotic Pressure Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.8.1.2. Hydrodynamic Pressure Activated
        • 5.8.1.2.1. Hydrodynamic Pressure Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.8.1.3. Vapor Pressure Activated
        • 5.8.1.3.1. Vapor Pressure Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.8.1.4. Mechanically Activated
        • 5.8.1.4.1. Mechanically Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.8.1.5. Magnetically Activated
        • 5.8.1.5.1. Magnetically Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Chemically Activated
    • 5.9.1. Chemically Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.9.1.1. pH Activated
        • 5.9.1.1.1. pH Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.9.1.2. Hydrolysis Activated
        • 5.9.1.2.1. Hydrolysis Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.9.1.3. Enzyme Activated
        • 5.9.1.3.1. Enzyme Activated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Controlled-Release Drug Delivery Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Controlled Release Drug Delivery Market: Application Movement Analysis
  • 6.3. Controlled Release Drug Delivery Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Metered Dose Inhalers
    • 6.5.1. Metered Dose Inhalers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Injectable
    • 6.6.1. Injectable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Transdermal and Ocular Patches
    • 6.7.1. Transdermal and Ocular Patches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Infusion Pumps
    • 6.8.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Oral Controlled-Drug Delivery Systems
    • 6.9.1. Oral Controlled-Drug Delivery Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Drug Eluting Stents
    • 6.10.1. Drug Eluting Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Global Controlled-Release Drug Delivery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Controlled Release Drug Delivery Market Movement Analysis
  • 7.3. Controlled-Release Drug Delivery Market: Regional Estimates & Trend Analysis by Product & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Controlled Release Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Johnson & Johnson
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Pfizer Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Merck & Co., Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. AbbVie Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Novartis AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Bayer AG
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. AstraZeneca plc
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Corium International, Inc
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Alkermes plc
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Amneal Pharmaceuticals
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table. 1 List of secondary sources
  • Table. 2 List of abbreviations
  • Table. 3 Global controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 4 Global controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 5 Global controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 6 North America controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 7 North America controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 8 North America controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 9 North America controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 10 North America controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 11 U.S. controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 12 U.S. controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 13 U.S. controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 14 Canada controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 15 Canada controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 16 Canada controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 17 Canada controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 18 Europe controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 19 Europe controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 20 Europe controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 21 Europe controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 22 Germany controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 23 Germany controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 24 Germany controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 25 Germany controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 26 UK controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 27 UK controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 28 UK controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 29 UK controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 30 France controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 31 France controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 32 France controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 33 France controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 34 Italy controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 35 Italy controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 36 Italy controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 37 Italy controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 38 Spain controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 39 Spain controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 40 Spain controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 41 Spain controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 42 Netherlands controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 43 Netherlands controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 44 Netherlands controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 45 Netherlands controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 46 Switzerland controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 47 Switzerland controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 48 Switzerland controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 49 Switzerland controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 50 Russia controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 51 Russia controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 52 Russia controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 53 Russia controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 54 Sweden controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 55 Sweden controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 56 Sweden controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 57 Sweden controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 58 Asia Pacific controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 59 Asia Pacific controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 60 Asia Pacific controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 61 Asia Pacific controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 62 Japan controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 63 Japan controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 64 Japan controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 65 Japan controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 66 China controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 67 China controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 68 China controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 69 China controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 70 India controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 71 India controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 72 India controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 73 India controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 74 South Korea controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 75 South Korea controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 76 South Korea controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 77 South Korea controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 78 Thailand controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 79 Thailand controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 80 Thailand controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 81 Indonesia controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 82 Indonesia controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 83 Indonesia controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 84 Indonesia controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 85 Indonesia controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 86 Philippines controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 87 Philippines controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 88 Philippines controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 89 Philippines controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 90 Latin America controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 91 Latin America controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 92 Latin America controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 93 Latin America controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 94 Latin America controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 95 Brazil controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 96 Brazil controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 97 Brazil controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 98 Brazil controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 99 Brazil controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 100 Mexico controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 101 Mexico controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 102 Mexico controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 103 Mexico controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 104 Argentina controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 105 Argentina controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 106 Argentina controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 107 Argentina controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 108 Middle East controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 109 Middle East controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 110 Middle East controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 111 Middle East controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 112 South Africa controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 113 South Africa controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 114 South Africa controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 115 South Africa controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 116 Saudi Arabia controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 117 Saudi Arabia controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 118 Saudi Arabia controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 119 Saudi Arabia controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 120 UAE controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 121 UAE controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 122 UAE controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 123 UAE controlled release drug delivery market, by application, 2021 - 2033 (USD Million)
  • Table. 124 Kuwait controlled release drug delivery market, by region, 2021 - 2033 (USD Million)
  • Table. 125 Kuwait controlled release drug delivery market, by technology, 2021 - 2033 (USD Million)
  • Table. 126 Kuwait controlled release drug delivery market, by release mechanism, 2021 - 2033 (USD Million)
  • Table. 127 Kuwait controlled release drug delivery market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Controlled release drug delivery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based size & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global controlled release drug delivery market revenue
  • Fig. 9 Market snapshot (regional)
  • Fig. 10 Segment snapshot (technology)
  • Fig. 11 Segment snapshot (release mechanism)
  • Fig. 12 Segment snapshot (application)
  • Fig. 13 Market concentration
  • Fig. 14 Controlled release drug delivery market and drug delivery devices market value, 2024 (USD billion)
  • Fig. 15 Controlled release drug delivery market dynamics
  • Fig. 16 Controlled release drug delivery market: PORTER's analysis
  • Fig. 17 Controlled release drug delivery market: PESTEL analysis
  • Fig. 18 Controlled release drug delivery market, by technology: Key takeaways
  • Fig. 19 Controlled release drug delivery market, by technology: Market share, 2024 & 2033
  • Fig. 20 Wurster technique market, 2021 - 2033 (USD Billion)
  • Fig. 21 Coacervation market, 2021 - 2033 (USD Billion)
  • Fig. 22 Micro encapsulation market, 2021 - 2033 (USD Billion)
  • Fig. 23 Implants market, 2021 - 2033 (USD Billion)
  • Fig. 24 Transdermal market, 2021 - 2033 (USD Billion)
  • Fig. 25 Targeted delivery market, 2021 - 2033 (USD Billion)
  • Fig. 26 Others market, 2021 - 2033 (USD Billion)
  • Fig. 27 Controlled release drug delivery market, by release mechanism: Key takeaways
  • Fig. 28 Controlled release drug delivery market, by release mechanism: Market share, 2024 & 2033
  • Fig. 29 Polymer matrix-based systems market, 2021 - 2033 (USD Billion)
  • Fig. 30 Micro reservoir partition-controlled drug delivery systems market, 2021 - 2033 (USD Billion)
  • Fig. 31 Feedback regulated drug delivery systems market, 2021 - 2033 (USD Billion)
  • Fig. 32 Activation-modulated drug delivery systems market, 2021 - 2033 (USD Billion)
  • Fig. 33 Osmotic pressure activated market, 2021 - 2033 (USD Billion)
  • Fig. 34 Hydrodynamic pressure activated market, 2021 - 2033 (USD Billion)
  • Fig. 35 Vapor pressure activated market, 2021 - 2033 (USD Billion)
  • Fig. 36 Mechanically activated market, 2021 - 2033 (USD Billion)
  • Fig. 37 Magnetically activated market, 2021 - 2033 (USD Billion)
  • Fig. 38 Chemically activated market, 2021 - 2033 (USD Billion)
  • Fig. 39 pH activated market, 2021 - 2033 (USD Billion)
  • Fig. 40 Hydrolysis activated market, 2021 - 2033 (USD Billion)
  • Fig. 41 Enzyme activated market, 2021 - 2033 (USD Billion)
  • Fig. 42 Controlled release drug delivery market, by application: Key takeaways
  • Fig. 43 Controlled release drug delivery market, by application: Market share, 2024 & 2033
  • Fig. 44 Metered dose inhalers market, 2021 - 2033 (USD Billion)
  • Fig. 45 Injectable market, 2021 - 2033 (USD Billion)
  • Fig. 46 Transdermal and ocular patches market, 2021 - 2033 (USD Billion)
  • Fig. 47 Infusion pumps market, 2021 - 2033 (USD Billion)
  • Fig. 48 Oral controlled-drug delivery systems market, 2021 - 2033 (USD Billion)
  • Fig. 49 Drug eluting stents market, 2021 - 2033 (USD Billion)
  • Fig. 50 Controlled release drug delivery market revenue, by region, 2024 & 2033 (USD Billion)
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 Estimated number of new cancer cases and deaths by State - 2024
  • Fig. 55 Adult Asthma by State, 2023
  • Fig. 56 Diagnosed diabetes - total, adults aged 18+ years, age-adjusted percentage (2023)
  • Fig. 57 Reimbursement procurement process
  • Fig. 58 U.S. controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Asthma, age standardized incidence rate, per 100,000, age 1 year and older, Canada
  • Fig. 60 Diabetes mellitus (types combined), excluding gestational diabetes, age-standardized incidence rate, per 100,000, age 1 year old and older, Canada
  • Fig. 61 Canada controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Europe controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 UK controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 Germany controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 65 France controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 Italy controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 67 Spain controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 68 Switzerland controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 69 Sweden controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 70 Netherlands controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 71 Belgium controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 72 Russia controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 73 Asia Pacific controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 74 China controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 75 Japan controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 76 India controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 77 Thailand controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 78 South Korea controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 79 Indonesia controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 80 Philippines controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 81 Vietnam controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 82 Singapore controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 83 Malaysia controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 84 Latin America controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 85 Brazil controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 86 Mexico controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 87 Argentina controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 88 Colombia controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 89 Chile controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 90 Middle East & Africa controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 91 South Africa controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 92 Saudi Arabia controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 93 UAE controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 94 Kuwait controlled release drug delivery market estimates and forecasts, 2021 - 2033 (USD Billion)